Yusuf Mathai
Family Medicine · Tualatin, ORNPI 1588919799
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,117 and has fallen 63.0% since, to $414 in 2025. Among family medicine clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $23.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$341
- Corcept Therapeutics$302
- Pfizer$267
- Bayer$257
- Lilly USA, LLC$216
- Takeda Pharmaceuticals U.S.A., Inc.$187
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,586100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $341 |
| Corcept Therapeutics | 11 | $302 |
| Pfizer | 13 | $267 |
| Bayer | 10 | $257 |
| Lilly USA, LLC | 7 | $216 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $187 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $151 |
| Dermira, Inc. | 1 | $125 |
| AbbVie | 5 | $122 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $91 |
| Exact Sciences | 3 | $69 |
| Novartis | 3 | $68 |
| Upsher-smith Laboratories LLC | 3 | $57 |
| Amarin Pharma, Inc. | 2 | $43 |
| Harmony Biosciences LLC | 1 | $40 |
| VBI Vaccine (delaware) Inc. | 1 | $38 |
| Shire North American Group Inc | 2 | $35 |
| Edwards Lifesciences | 1 | $29 |
| GSK | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Abbott | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| MDD US Operations, LLC | 1 | $17 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,586 in reported general payments places this provider in the 90th percentile of 1,221 family medicine providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,544 |
| Estradiol (Once Weekly)Estradiol | 21 | $1,133 |
| Fentanyl | 13 | $922 |
| ProgesteroneProgesterone, Micronized | 30 | $917 |
| Quetiapine Fumarate | 13 | $674 |
| Mirtazapine | 22 | $531 |
| Felodipine ErFelodipine | 18 | $531 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 21 | $482 |
| Diltiazem Hcl | 13 | $327 |
| Trazodone Hcl | 19 | $279 |
| Lisinopril | 33 | $243 |
| Levothyroxine Sodium | 16 | $233 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $209 |
| Amlodipine Besylate | 15 | $200 |
| Metformin Hcl | 20 | $163 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tualatin
- Warren OkunsTualatin$5K
- Eden MillerBend$1.7M
- Anil RajaniHood River$325K
- Stephen NelsonMedford$101K
- Karen KahnAshland$86K
- Robert GobboPortland$53K
- Kevin MillerSisters$39K
- Morris MaizelsCentral Point$25K
- Maureen MaysPortland$24K
- Nathaniel FondellMedford$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.